Guidance on patient Identification and Administration of Recombinant Human Activated protein C for the Treatment of Severe Sepsis
Gary Garber(University of Ottawa), James A. Russell(University of British Columbia), Claudio M. Martin(Western University), Jean‐Gilles Guimond, Sheldon Magder(McGill University Health Centre), Kenneth Cunningham(Lions Gate Hospital), Bruce Light(St. Boniface Hospital), R. T. Noel Gibney(University of Alberta Hospital)
Cited by 13
Related Papers
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
|New England Journal of Medicine|1999|5.2k
Vasopressin versus Norepinephrine Infusion in Patients with Septic Shock
|New England Journal of Medicine|2008|1.9k
Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
|CHEST Journal|2009|1.2k
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
|Clinical Infectious Diseases|2014|1.1k
Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever
|New England Journal of Medicine|2002|986